After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Genmab ADR is $20.91B. A total of 1.48 million shares were traded on the day, compared to an average of 1.85M shares.
In the most recent transaction, GENMAB A/S bought 1,052,806 shares of GMAB for 97.00 per share on Dec 29 ’25. After the transaction, the 10% Owner now owns 73,884,293 company shares. In a previous transaction on Dec 26 ’25, GENMAB A/S bought 2,978 shares at 97.00 per share. GMAB shares that 10% Owner owns now total 72,831,487.
Among the insiders who bought shares, GENMAB A/S acquired of 561,042 shares on Dec 23 ’25 at a per-share price of $97.00. This resulted in the 10% Owner holding 72,589,817 shares of GMAB after the transaction. In another insider transaction, GENMAB A/S bought 142,610 shares at $97.00 per share on Dec 26 ’25. Company shares held by the 10% Owner now total 72,828,509.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, GMAB has a high of $34.29 and a low of $17.24.
As of this writing, GMAB has an earnings estimate of $0.42 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of $0.5 per share and a lower estimate of $0.35. The company reported an EPS of $0.84 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GMAB’s latest balance sheet shows that the firm has $2.94B in Cash & Short Term Investments as of fiscal 2021. There were $64.70M in debt and $238.71M in liabilities at the time. Its Book Value Per Share was $9.34, while its Total Shareholder’s Equity was $3.38B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock.
